Literature DB >> 32962500

Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.

Xuewen Yang1, Feng Lin2, Feng Gao1.   

Abstract

BACKGROUND: Long non-coding RNAs (lncRNAs) have been confirmed to participate in the regulation of nasopharyngeal carcinoma. Here, we endeavored to explore the character of lncRNA ILF3-AS1 in the nasopharyngeal carcinoma and its function.
METHODS: A total of 68 nasopharyngeal carcinoma tissues and adjacent normal nasopharyngeal tissues were collected. Expressions of lncRNA ILF3-AS1 in these tissues were detected using quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between the expression level of lncRNA ILF3-AS1 and clinical pathological characteristics was analyzed. Inhibition of lncRNA ILF3-AS1 was done using small interference RNA.
RESULTS: lncRNA ILF3-AS1 expression was significantly up-regulated in the 68 nasopharyngeal carcinoma tissue samples compared to their adjacent normal tissue samples. Increased lncRNA ILF3-AS1 level was related to the advanced tumor node metastasis stage and the metastasis of nasopharyngeal carcinoma. Also, increased lncRNA ILF3-AS1 indicated poor prognosis of nasopharyngeal carcinoma patients. Inhibition of lncRNA ILF3-AS1 reduced proliferation, invasion and migration of nasopharyngeal carcinoma cells. MicroRNA-320a (miR-320a) was determined as a direct target for lncRNA ILF3-AS1 in nasopharyngeal carcinoma. Furthermore, lncRNA ILF3-AS1 could sponge miR-320a to promote BMI1 expression. The expression of BMI1 was significantly inhibited by the down-regulation of lncRNA ILF3-AS1.
CONCLUSIONS: For the first time, we demonstrated that lncRNA ILF3-AS1 was markedly over-expressed in nasopharyngeal carcinoma tissues and cells. Elevated lncRNA ILF3-AS1 expression was correlated with severe cancer stage and poor prognosis. lncRNA ILF3-AS1 could promote proliferation, invasion, and migration of cells, which might indicate a novel target site for the future diagnosis and therapy of nasopharyngeal carcinoma.

Entities:  

Keywords:  BMI1; NPC; lncRNA ILF3-AS1; miR-320; progression

Mesh:

Substances:

Year:  2020        PMID: 32962500     DOI: 10.1177/1724600820955199

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  5 in total

1.  Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m6A-dependent manner.

Authors:  Changwen Bo; Na Li; Li He; Sujing Zhang; Yonghui An
Journal:  Hum Cell       Date:  2021-09-07       Impact factor: 4.174

2.  LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis.

Authors:  Wei Liu; Shan Li
Journal:  Onco Targets Ther       Date:  2021-03-12       Impact factor: 4.147

3.  SARS-CoV-2 Airway Infection Results in Time-dependent Sensory Abnormalities in a Hamster Model.

Authors:  Randal A Serafini; Justin J Frere; Jeffrey Zimering; Ilinca M Giosan; Kerri D Pryce; Ilona Golynker; Maryline Panis; Anne Ruiz; Benjamin tenOever; Venetia Zachariou
Journal:  bioRxiv       Date:  2022-08-19

4.  Long noncoding RNA ILF3-AS1 aggravates papillary thyroid carcinoma progression via regulating the miR-4306/PLAGL2 axis.

Authors:  Zhaohui Zeng; Qiangfeng Teng; Jinhong Xiao
Journal:  Cancer Cell Int       Date:  2021-06-27       Impact factor: 5.722

Review 5.  MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Authors:  Yuanyuan Liang; Shun Li; Liling Tang
Journal:  Biomedicines       Date:  2021-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.